FDA Approved: VEOZAH — Original Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved VEOZAH (fezolinetant) from Astellas as a first-in-class non-hormonal treatment for vasomotor symptoms related to menopause. This marks a novel …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vasomotor Symptoms Related to Menopause

Drugs mentioned

• VEOZAH (fezolinetant)

Snippet

ORIG AP for VEOZAH (FEZOLINETANT)